Abood Okal

Abood Okal

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4517010
武田薬品工業株式会社
person_outline Abood Okal's MOST POPULAR ARTICLES
1-) Direct induction of apoptosis using an optimal mitochondrially targeted p53M Mossalam, KJ Matissek, A Okal, JE Constance, CS LimMolecular pharmaceutics 9 (5), 1449-1458, 2012412012
2-) The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondriaKJ Matissek, M Mossalam, A Okal, CS LimMolecular pharmaceutics 10 (10), 3592-3602, 2013232013
3-) Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor MicroenvironmentJJ Jackson, JM Ketcham, A Younai, B Abraham, B Biannic, HP Beck, ...Journal of Medicinal Chemistry 62 (13), 6190-6213, 2019252019
4-) A chimeric p53 evades mutant p53 transdominant inhibition in cancer cellsA Okal, M Mossalam, KJ Matissek, AS Dixon, PJ Moos, CS LimMolecular pharmaceutics 10 (10), 3922-3933, 2013262013
5-) Delivery of a monomeric p53 subdomain with mitochondrial targeting signals from pro-apoptotic Bak or BaxKJ Matissek, A Okal, M Mossalam, CS LimPharmaceutical research 31, 2503-2515, 2014232014